Clinical trial · Interventional
Increasing Colorectal Cancer Screening Uptake With a Patient Navigator
Increasing Colorectal Cancer Screening Uptake With a Patient Navigator - Phase III Trial
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Patients who receive tailored navigation (consisting of a letter and patient navigation services) and get screened will be significantly greater than the control group who receives treatment as usual. A majority of patients will opt for Fecal Occult Blood Testing (FOBT)as one of their preferred tests, after undergoing the "Patient Navigator" intervention and that proportion will be significantly greater than the group who opt for FOBT in the control group.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Colorectal Cancer | Malignant Colorectal Neoplasm | CURATED_BROADER | 0.80 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Health counselling by nurse navigator | Behavioral | — | UNRESOLVED |
| Usual primary care counselling | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Navigator intervention
- interventionNames
- Behavioral: Health counselling by nurse navigator
- type
- ACTIVE_COMPARATOR
- label
- Usual Care Control
- description
- Usual care
- interventionNames
- Behavioral: Usual primary care counselling
Primary outcomes (1)
- measure
- Completion of verified CRC screening event (FOBT;colonoscopy) event in experimental vs. control groups within 48 weeks
- timeFrame
- 48 weeks after baseline assessment
- description
- Completion of verified CRC screening events in experimental vs. control patients
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 50 Years
- Maximum age
- 74 Years
Show eligibility criteria text
Inclusion Criteria: * Average risk men and women aged 50 - 74 * Unscreened - Defined as no prior CRC screening * Under-screened - Defined as no FOBT screening within the last two years * No colonoscopy or barium enema screening within the last five years * Willing to provide consent to participate in the study. Exclusion Criteria: * FOBT within the last two years * colonoscopy within five years * barium enema within five years * flexible sigmoidoscopy within five years * Bowel cancer.
References
Publications (0)
Data not yet available